Clinical Trials Browser

Phase 2 × Smoldering Multiple Myeloma × elotuzumab × Clear all

NCT02279394 2023-06-09

E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Phase 2 Completed

51 enrolled 14 charts

Smoldering Multiple Myeloma

NCT01441973 2018-01-23

Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

Phase 2 Completed

41 enrolled 17 charts

Smoldering Multiple Myeloma